魏子翰 (2009) 同步分析人類血清白蛋白中萘及雌性激素醌類代謝物之蛋白質胼合物。國立中興大學環境工程研究所碩士論文,台灣台中。林慶全 (2011) 運用血清白蛋白為生物指標探討體內累積隻雌性激素-3,4-苯醌代謝物作為乳癌風險預測指標之研究。國立中興大學環境工程研究所碩士論文,台灣台中。葛茂輝 (2012) 運用蛋白質胼合物作為生物指標探討乳癌風險因子與體內雌性激素與萘苯醌累積劑量之相關性分析。國立中興大學環境工程研究所碩士論文,台灣台中。蔡明翰 (2015) 探討塑化劑對雌性激素於人類MCF-7乳腺細胞所誘發基因毒性之影響。國立中興大學環境工程研究所碩士論文,台灣台中。廖意倫 (2016) 探討多環芳香族碳氫化合物之環境暴露與乳癌風險之相關性研究。國立中興大學環境工程研究所碩士論文,台灣台中。林聰芬 (2017)雌性激素血紅蛋白併合物與乳癌診斷與治療指標之相關性研究。國立中興大學環境工程研究所碩士論文,台灣台中。行政院衛生福利部國民健康署 (2016) 中華民國103年癌症登記報告。
國立臺灣大學醫學院附設醫院乳房醫學中心 參考網址:https://www.ntuh.gov.tw/BC/AboutUs/認識乳癌.aspx
Autrup, H., B. Daneshvar, L. O. Dragsted, M. Gamborg, M. Hansen, S. Loft, H. Okkels, F. Nielsen, P. S. Nielsen, E. Raffn, H. Wallin and L. E. Knudsen (1999). "Biomarkers for exposure to ambient air pollution--comparison of carcinogen-DNA adduct levels with other exposure markers and markers for oxidative stress." Environ Health Perspect 107(3): 233-238.
Bolton, J. L. and G. R. Thatcher (2008). "Potential mechanisms of estrogen quinone carcinogenesis." Chem Res Toxicol 21(1): 93-101.
Butcher, J. T., T. Johnson, J. Beers, L. Columbus and B. E. Isakson (2014). "Hemoglobin alpha in the blood vessel wall." Free Radic Biol Med 73: 136-142.
Carey La, P. C. M. L. C. A. and et al. (2006). "RAce, breast cancer subtypes, and survival in the carolina breast cancer study." JAMA 295(21): 2492-2502.
Cavalieri, E., D. Chakravarti, J. Guttenplan, E. Hart, J. Ingle, R. Jankowiak, P. Muti, E. Rogan, J. Russo, R. Santen and T. Sutter (2006). "Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention." Biochim Biophys Acta 1766(1): 63-78.
Cavalieri, E. and E. Rogan (2006). "Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture." Ann N Y Acad Sci 1089: 286-301.
Cavalieri, E. L. and E. G. Rogan (2011). "Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer." Journal of Steroid Biochemistry and Molecular Biology 125(3-5): 169-180.
Cavalieri, E. L., D. E. Stack, P. D. Devanesan, R. Todorovic, I. Dwivedy, S. Higginbotham, S. L. Johansson, K. D. Patil, M. L. Gross, J. K. Gooden, R. Ramanathan, R. L. Cerny and E. G. Rogan (1997). "Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators." Proceedings of the National Academy of Sciences of the United States of America 94(20): 10937-10942.
Cavalieri, E. L., D. E. Stack, P. D. Devanesan, R. Todorovic, I. Dwivedy, S. Higginbotham, S. L. Johansson, K. D. Patil, M. L. Gross, J. K. Gooden, R. Ramanathan, R. L. Cerny and E. G. Rogan (1997). "Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators." Proc Natl Acad Sci U S A 94(20): 10937-10942.
Chakravarti, D., P. C. Mailander, K. M. Li, S. Higginbotham, H. L. Zhang, M. L. Gross, J. L. Meza, E. L. Cavalieri and E. G. Rogan (2001). "Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene." Oncogene 20(55): 7945-7953.
Chang, T. J., W. J. Lee, H. M. Chang, K. C. Lee and L. M. Chuang (2008). "Expression of subcutaneous adipose tissue phosphoenolpyruvate carboxykinase correlates with body mass index in nondiabetic women." Metabolism 57(3): 367-372.
Chen, D. R., S. T. Chen, T. W. Wang, C. H. Tsai, H. H. Wei, G. J. Chen, T. C. Yang, C. Lin and P. H. Lin (2011). "Characterization of estrogen quinone-derived protein adducts and their identification in human serum albumin derived from breast cancer patients and healthy controls." Toxicol Lett 202(3): 244-252.
Chetrite, G. S., J. Cortes-Prieto, J. C. Philippe, F. Wright and J. R. Pasqualini (2000). "Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues." J Steroid Biochem Mol Biol 72(1-2): 23-27.
Clemons, M. and P. Goss (2001). "Estrogen and the risk of breast cancer." N Engl J Med 344(4): 276-285.
Convert, O., C. Van Aerden, L. Debrauwer, E. Rathahao, H. Molines, F. Fournier, J. C. Tabet and A. Paris (2002). "Reactions of estradiol-2,3-quinone with deoxyribonucleosides: possible insights in the reactivity of estrogen quinones with DNA." Chem Res Toxicol 15(5): 754-764.
Dawling, S., N. Roodi, R. L. Mernaugh, X. H. Wang and F. F. Parl (2001). "Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: Comparison of wild-type and variant COMT isoforms." Cancer Research 61(18): 6716-6722.
DeSantis, C., R. Siegel, P. Bandi and A. Jemal (2011). "Breast cancer statistics, 2011." CA Cancer J Clin 61(6): 409-418.
Ehrenberg, H. L., K. D., Osterman-Golkar and W. S., I. (1974). "Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutation Research. 24, 83-103.".
Eliassen, A. H., G. A. Colditz, B. Rosner, W. C. Willett and S. E. Hankinson (2006). "Adult weight change and risk of postmenopausal breast cancer." JAMA 296(2): 193-201.
Ferrer, J., J. L. Neyro and A. Estevez (2005). "Identification of risk factors for prevention and early diagnosis of a-symptomatic post-menopausal women." Maturitas 52 Suppl 1: S7-22.
Friedenreich, C. M. (2001). "Review of anthropometric factors and breast cancer risk." Eur J Cancer Prev 10(1): 15-32.
Hayes, C. L., D. C. Spink, B. C. Spink, J. Q. Cao, N. J. Walker and T. R. Sutter (1996). "17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1." Proceedings of the National Academy of Sciences of the United States of America 93(18): 9776-9781.
He, X., G. Yao, F. Li, M. Li and X. Yang (2014). "Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China." Int J Mol Sci 15(2): 2130-2141.
Huang, C. S., C. H. Lin, Y. S. Lu and C. Y. Shen (2010). "Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example." J Steroid Biochem Mol Biol 118(4-5): 300-303.
Jefcoate, C. R., J. G. Liehr, R. J. Santen, T. R. Sutter, J. D. Yager, W. Yue, S. J. Santner, R. Tekmal, L. Demers, R. Pauley, F. Naftolin, G. Mor and L. Berstein (2000). "Tissue-specific synthesis and oxidative metabolism of estrogens." J Natl Cancer Inst Monogr(27): 95-112.
Jiang, C., S. Yu, P. Qian, R. Guo, R. Zhang, Z. Ao, Q. Li, G. Wu, Y. Chen, J. Li, C. Wang, W. Yao, J. Xu, G. Qian and F. Ji (2016). "The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population." Oncotarget 7(37): 59742-59753.
Karl, H., A. Herman and H. and Aage (1995). "DNA and protein adducts. Toxicology. 101,41-53.".
Lavigne, J. A., J. E. Goodman, T. Fonong, S. Odwin, P. He, D. W. Roberts and J. D. Yager (2001). "The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells." Cancer Res 61(20): 7488-7494.
Li, Y., J. Yao, M. Chang, M. Cuendet and J. L. Bolton (2004). "Altered apoptotic response in MCF 10A cells treated with the equine estrogen metabolite, 4-hydroxyequilenin." Toxicol Lett 154(3): 225-233.
Liehr, J. G. (2000). "Is estradiol a genotoxic mutagenic carcinogen?" Endocr Rev 21(1): 40-54.
Liehr, J. G., W. F. Fang, D. A. Sirbasku and A. Ari-Ulubelen (1986). "Carcinogenicity of catechol estrogens in Syrian hamsters." J Steroid Biochem 24(1): 353-356.
Liehr, J. G. and M. J. Ricci (1996). "4-Hydroxylation of estrogens as marker of human mammary tumors." Proc Natl Acad Sci U S A 93(8): 3294-3296.
Lin, C., D. R. Chen, W. C. Hsieh, W. F. Yu, C. C. Lin, M. H. Ko, C. H. Juan, B. J. Tsuang and P. H. Lin (2013). "Investigation of the cumulative body burden of estrogen-3,4-quinone in breast cancer patients and controls using albumin adducts as biomarkers." Toxicol Lett 218(3): 194-199.
Lin, C., W. C. Hsieh, D. R. Chen, S. J. Kuo, W. F. Yu, S. W. Hu, H. J. Sue, M. H. Ko, C. H. Juan, K. S. Chung and P. H. Lin (2014). "Hemoglobin adducts as biomarkers of estrogen homeostasis: elevation of estrogenquinones as a risk factor for developing breast cancer in Taiwanese women." Toxicol Lett 225(3): 386-391.
Lyon, F. (2007). "World Health Organization., International Agency for Research on Cancer.
and IARC Working Group on the Evaluation of Carcinogenic Risks to Humans."
McPherson, K., C. M. Steel and J. M. Dixon (2000). "ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics." BMJ 321(7261): 624-628.
McVeigh, T. P., S. Y. Jung, M. J. Kerin, D. Salzman, S. Nallur, A. A. Nemec, M. Dookwah, J. Sadofsky, T. Paranjape, O. Kelly, E. Chan, N. Miller, K. J. Sweeney, D. Zelterman, J. Sweasy, R. Pilarski, D. Telesca, F. J. Slack and J. B. Weidhaas (2015). "Estrogen Withdrawal, Increased Breast Cancer Risk and the KRAS-variant." Cell Cycle: 0.
Melikian, A. A., P. Sun, B. Prokopczyk, K. El-Bayoumy, D. Hoffmann, X. Wang and S. Waggoner (1999). "Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry." Cancer Lett 146(2): 127-134.
Minghetti, P. P., D. E. Ruffner, W. J. Kuang, O. E. Dennison, J. W. Hawkins, W. G. Beattie and A. Dugaiczyk (1986). "Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4." J Biol Chem 261(15): 6747-6757.
Muskhelishvili, L., P. A. Thompson, D. F. Kusewitt, C. Wang and F. F. Kadlubar (2001). "In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues." J Histochem Cytochem 49(2): 229-236.
Nagai, M., A. H. Conney and B. T. Zhu (2004). "Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase." Drug Metab Dispos 32(5): 497-504.
Newbold, R. R. and J. G. Liehr (2000). "Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens." Cancer Res 60(2): 235-237.
Nielsen, P. S., H. Okkels, T. Sigsgaard, S. Kyrtopoulos and H. Autrup (1996). "Exposure to urban and rural air pollution: DNA and protein adducts and effect of glutathione-S-transferase genotype on adduct levels." Int Arch Occup Environ Health 68(3): 170-176.
Parl, F. F., K. M. Egan, C. Li and P. S. Crooke (2009). "Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction." Cancer Inform 7: 109-121.
Pasqualini, J. R., G. Chetrite, C. Blacker, M. C. Feinstein, L. Delalonde, M. Talbi and C. Maloche (1996). "Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients." J Clin Endocrinol Metab 81(4): 1460-1464.
Paul, L. and R. Steven (1990). "Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogen. 11(4),507-518.".
Ratanachoo, K., P. R. Gascoyne and M. Ruchirawat (2002). "Detection of cellular responses to toxicants by dielectrophoresis." Biochim Biophys Acta 1564(2): 449-458.
Rossouw, J. E., G. L. Anderson, R. L. Prentice, A. Z. LaCroix, C. Kooperberg, M. L. Stefanick, R. D. Jackson, S. A. Beresford, B. V. Howard, K. C. Johnson, J. M. Kotchen, and and J. Ockene (2002). "Risks and benefits of estrogen plus progestin in healthy
postmenopausal women: principal results From the Women's Health Initiative
randomized controlled trial. Jama, 288, 321‐33.".
Rossouw, J. E., G. L. Anderson, R. L. Prentice, A. Z. LaCroix, C. Kooperberg, M. L. Stefanick, R. D. Jackson, S. A. Beresford, B. V. Howard, K. C. Johnson, J. M. Kotchen and J. Ockene (2002). "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial." Jama 288(3): 321-333.
Sanderson, J. T., L. Slobbe, G. W. Lansbergen, S. Safe and M. van den Berg (2001). "2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells." Toxicol Sci 61(1): 40-48.
Skipper, P. L. and S. R. Tannenbaum (1990). "Protein adducts in the molecular dosimetry of chemical carcinogens." Carcinogenesis 11(4): 507-518.
Smith, I. E. and M. Dowsett (2003). "Aromatase inhibitors in breast cancer." N Engl J Med 348(24): 2431-2442.
Spink, D. C., B. C. Spink, J. Q. Cao, J. F. Gierthy, C. L. Hayes, Y. Li and T. R. Sutter (1997). "Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells." J Steroid Biochem Mol Biol 62(2-3): 223-232.
Törnqvist, M., J. Mowrer, S. Jensen and L. and Ehrenberg (1986). "Monitoring of environmental cancer initiators through hemoglobin adducts by a modifiedEdman degradation method. Analytical Biochemistry. 154,255-266.".
Thull, D. L. and V. G. Vogel (2004). "Recognition and Management of Hereditary Breast Cancer Syndromes." The Oncologist 9(1): 13-24.
Tornqvist, M., C. Fred, J. Haglund, H. Helleberg, B. Paulsson and P. Rydberg (2002). "Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications." J Chromatogr B Analyt Technol Biomed Life Sci 778(1-2): 279-308.
Turesky, R. J. and L. Le Marchand (2011). "Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines." Chem Res Toxicol 24(8): 1169-1214.
Vogel, V. G. (2008). "Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer." Menopause 15(4): 782-789 710.1097/gme.1090b1013e3181788d3181788.
Yager, J. D. (2000). "Endogenous estrogens as carcinogens through metabolic activation." J Natl Cancer Inst Monogr(27): 67-73.
Yager, J. D. and N. E. Davidson (2006). "Estrogen carcinogenesis in breast cancer." N Engl J Med 354(3): 270-282.
Yager, J. D. and N. E. Davidson (2006). "Mechanisms of disease: Estrogen carcinogenesis in breast cancer." New England Journal of Medicine 354(3): 270-282.